anthracycline + cyclophosphamide + vincristine

This is a combination chemotherapy regimen consisting of an anthracycline (such as doxorubicin or daunorubicin), cyclophosphamide, and vincristine. Each component has a distinct mechanism of action: - Anthracyclines (e.g., doxorubicin, daunorubicin) are cytotoxic antibiotics that intercalate DNA and inhibit topoisomerase II, leading to DNA damage and apoptosis in rapidly dividing cells. - Cyclophosphamide is an alkylating agent that crosslinks DNA strands, preventing cell division and leading to cell death. - Vincristine is a vinca alkaloid that inhibits microtubule formation in mitosis, arresting cells in metaphase. This combination targets cancer cells at different points in the cell cycle for synergistic antineoplastic effects. It has been used as part of various regimens for hematologic malignancies such as lymphomas and leukemias[5][7]. The specific anthracycline used may vary depending on the protocol.